Personal Independence Payment: Cancer

(asked on 13th November 2018) - View Source

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, pursuant to the Answer of 8 November to Question 187017 on Personal Independence Payment: Cancer, how many people with (a) leukaemia, (b) myeloma, (c) Hodgkin's lymphoma and (d) non-Hodgkin's lymphoma have (i) applied for personal independence payment and (ii) unsuccessfully appealed a decision not to award personal independence payment.


Answered by
Sarah Newton Portrait
Sarah Newton
This question was answered on 21st November 2018

Since Personal Independence Payment (PIP) was introduced up to June 2018, there have been:

(a) 5,780 decisions for people with a primary disabling condition of leukaemia. There were 90 appeals against disallowances, 30 of which were unsuccessful.

(b) 3,430 decision for people with a primary disabling condition of myeloma. There were 30 appeals against disallowances, fewer than five of which were unsuccessful.

(c) 2,680 decisions for people with a primary disabling condition of Hodgkin’s lymphoma. There were 40 appeals against disallowances, 10 of which were unsuccessful.

(d) 4,240 decisions for people with a primary disabling condition of non-Hodgkin’s lymphoma. There were 70 appeals against disallowance, 30 of which were unsuccessful.

The data at (a) to (d) has been rounded to the nearest 10. The number of decisions does not include people who applied for PIP but withdrew their application before their initial assessment.

Since PIP was introduced 3.5m decisions have been made up to June 2018, of these 9% have been appealed and 4% have been overturned.

The table below puts these figures in the context of the total number of disallowances and appeals. Numbers are rounded to the nearest 10. # denotes fewer than 5. Components of this answer and the answer to PQ187017 may not sum to totals due to rounding.

The number of decisions does not include people who applied for PIP but withdrew their application before their initial assessment.

PIP decisions, disallowances and appeals up to June 2018

(a) leukaemia

(b) myeloma

(c) Hodgkin’s lymphoma

(d) non-Hodgkin’s lymphoma

Number of decisions

5,780

3,430

2,680

4,240

Number of disallowances

1,040

350

490

680

Number of appeals against disallowances

90

30

40

70

Number of disallowances maintained at appeal

30

#

10

30

Not all Tribunal appeals will relate to the outcome of the PIP assessment, but other aspects of the PIP process. The appeals may include decisions which are changed at mandatory reconsideration, and where the claimant continues to appeal for a higher PIP award, are then changed again at tribunal appeal.

Data is based on primary disabling condition as recorded on the PIP computer systems. Claimants may often have multiple disabling conditions upon which the decision is based but only the primary condition is shown in these statistics.

Reticulating Splines